Value in Health

Proposal of Polish Guidelines for Conducting Financial Analysis and Their Comparison to Existing Guidance on Budget Impact in Other Countries
pp. 1-10(10)
Authors: Orlewska E.; Mierzejewski P.

Outcomes Research in Health Care: Simulations to Drive Cost Conclusions
pp. 11-12(2)
Authors: Frear R.; Motheral B.

Modeling the Efficiency of Reaching a Target Intermediate End Point: A Case Study in Type 2 Diabetes in the United States
pp. 13-21(9)
Authors: Caro J.J.; Salas M.; O'Brien J.A.; Ishak K.; Sung J.; Raggio G.

The Impact of Olanzapine, Risperidone, or Haloperidol on the Cost of Schizophrenia Care in a Medicaid Population
pp. 22-35(14)
Authors: Gibson P.J.; Damler R.; Jackson E.A.; Wilder T.; Ramsey J.L.

A Pharmacoeconomic Evaluation of Seven-Valent Pneumococcal Conjugate Vaccine in Spain
pp. 36-51(16)
Authors: Asensi F.; De Jose M.; Lorente M.; Moraga F.; Ciuryla V.; Arikian S.; Casciano R.; Vento M.

Using Clopidogrel in Non-ST-Segment Elevation Acute Coronary Syndrome Patients: A Cost–Utility Analysis in Spain
pp. 52-60(9)
Authors: Latour-Pérez J.; Navarro-Ruiz A.; Ridao-López M.; Cervera-Montes M.

Relationships of Clinical, Psychologic, and Individual Factors with the Functional Status of Neck Pain Patients
pp. 61-69(9)
Authors: Luo X.; Edwards C.L.; Richardson W.; Hey L.

Cost-Effectiveness versus Cost–Utility Analysis of Interventions for Cancer: Does Adjusting for Health-Related Quality of Life Really Matter?
pp. 70-78(9)
Author: Tengs T.O.

Assessment of Health-Related Quality of Life in Children: A Review of Conceptual, Methodological, and Regulatory Issues
pp. 79-92(14)
Authors: Matza L.S.; Swensen A.R.; Flood E.M.; Secnik K.; Leidy N.K.

A Comprehensive Strategy for the Interpretation of Quality-of-Life Data Based on Existing Methods
pp. 93-104(12)
Authors: Marquis P.; Chassany O.; Abetz L.

Letter to the Editor
pp. 105-106(2)